+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The vesicular monoamine transporter, in contrast to the dopamine transporter, is not regulated following chronic cocaine self-administration



The vesicular monoamine transporter, in contrast to the dopamine transporter, is not regulated following chronic cocaine self-administration



Society for Neuroscience Abstracts 21(1-3): 1382




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033975635

Download citation: RISBibTeXText


Related references

The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. Journal of Neuroscience 16(10): 3507-3510, 1996

The Vesicular Monoamine Transporter, in Contrast to the Dopamine Transporter, Is Not Altered by Chronic Cocaine Self-Administration in the Rat. The Journal of Neuroscience 16(10): 3507-3510, 1996

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Annals of Neurology 40(3): 428-439, 1996

Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Molecular Pharmacology 47(2): 368-373, 1995

Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Molecular Brain Research. 49(1-2): 137-148, 1997

Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates. Biological Psychiatry 77(5): 488-492, 2015

Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity. Synapse 61(7): 573-576, 2007

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain. Plos one 7(11): E49483, 2012

Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. Journal of Neurochemistry 111(5): 1202-1212, 2009

Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Methods in Molecular Medicine 62: 179-190, 2001

Coordinated expression of dopamine transporter and vesicular monoamine transporter in the primate striatum during development. Synapse 67(9): 580-585, 2013

Coordinated expression of dopamine transporter DAT and vesicular monoamine transporter VMAT2 in the primate striatum during development. 2013

Age-related decreases in striatal dopamine transporter and vesicular monoamine transporter binding sites in alcoholics. Alcoholism Clinical & Experimental Research 22(3 ABSTR Suppl. ): 48A, 1998

Aging effects on locomotor activity in dopamine transporter and vesicular monoamine transporter knockout mice. Society for Neuroscience Abstracts 26(1-2): Abstract No -344 5, 2000

Dopamine transporter and synaptic vesicular monoamine transporter expression and Parkinsons disease dopaminergic damage. Neurology 44(4 Suppl. 2): A282, 1994